Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · December 11, 2022

Risk of IOP Increase Associated With Intravitreal Injections of VEGF Inhibitors in Patients Without Diabetes

American Journal of Ophthalmology

 

Additional Info

American Journal of Ophthalmology
Risk of intraocular pressure increase with intravitreal injections of Vascular Endothelial Growth Factor Inhibitors: a cohort study
Am J Ophthalmol 2022 Nov 18;[EPub Ahead of Print], A Spini, S Giometto, S Donnini, M Posarelli, F Dotta, M Ziche, GM Tosi, A Girardi, E Lucenteforte, R Gini, M Etminan, G Virgili

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading